Kathleen Ford Kura Oncology, Inc. (KURA) insider trading activity

Kathleen Ford is Chief Operating Officer of Kura Oncology, Inc.. Currently has a direct ownership of 105,373 shares of KURA, which is worth approximately $1.18 Million. The most recent transaction as insider was on Nov 14, 2025, when has been sold 6,902 shares (Common Stock) at a price of $11.18 per share, resulting in proceeds of $77,164. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K

66.27% 3M change

354.51% 12M change

Total Value Held $1.18 Million

KATHLEEN FORD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 14 2025	SELL Open market or private sale	$77,164 $11.18 p/Share	6,902 Reduced 6.15%	105,373 Common Stock
Nov 13 2025	BUY Grant, award, or other acquisition	-	48,900 Added 30.34%	112,275 Common Stock
Sep 29 2025	SELL Open market or private sale	$61,614 $8.94 p/Share	6,892 Reduced 9.81%	63,375 Common Stock
Sep 27 2025	SELL Grant, award, or other acquisition	-	48,900 Reduced 41.03%	70,267 Common Stock
May 19 2025	SELL Open market or private sale	$9,784 $6.28 p/Share	1,558 Reduced 6.8%	21,367 Common Stock
Jan 28 2025	SELL Open market or private sale	$14,299 $7.87 p/Share	1,817 Reduced 7.84%	21,367 Common Stock
Nov 18 2024	SELL Open market or private sale	$8,431 $16.03 p/Share	526 Reduced 2.22%	23,184 Common Stock

Jan 29 2024	SELL Open market or private sale	$26,628 $17.8 p/Share	1,496 Reduced 6.48%	21,602 Common Stock
Jan 27 2023	SELL Open market or private sale	$25,293 $13.89 p/Share	1,821 Reduced 7.91%	21,214 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	21,900 Added 48.74%	23,035 Common Stock
Mar 15 2021	SELL Open market or private sale	$183,938 $29.43 p/Share	6,250 Reduced 100.0%	0 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$121,438 $19.43 p/Share	6,250 Added 50.0%	6,250 Common Stock
Dec 15 2020	SELL Open market or private sale	$380,625 $40.6 p/Share	9,375 Reduced 100.0%	0 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$182,156 $19.43 p/Share	9,375 Added 75.0%	3,125 Common Stock
Nov 10 2020	SELL Open market or private sale	$246,438 $39.43 p/Share	6,250 Reduced 100.0%	0 Common Stock
Nov 10 2020	BUY Exercise of conversion of derivative security	$121,438 $19.43 p/Share	6,250 Added 50.0%	6,250 Common Stock

Kathleen Ford

Chief Operating Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KURA shares.

Notify only if

Value

Insider Trading

Get notified when an Kura Oncology, Inc. insider buys or sells KURA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kura Oncology, Inc.

Track Activities on KURA

Account